Abstract
The term mitochondrial disorder (MD) encompasses a group of diseases that result from the structural, biochemical, or genetic derangement of mitochondria. In simple terms, MDs are disorders of deficient cellular energy production (1). The role of MD in aging and in a wide variety of systemic and neurologic disorders is increasingly recognized (2). Mitochondrial disorders may present as independent syndromes, complicate other medical disorders, or occur as complication of therapies used to treat other disorders (1). Most patients with MD are not diagnosed on initial presentation but present with recurrent episodic symptoms that elude diagnosis for months to years.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Clay AS, Behnia M, Brown KK. Mitochondrial disease. Chest 2001; 120: 634–648.
Graeber MB, Muller U. Recent developements in the molecular genetics of mitochondrial disorders. J. Neurol. Sci. 1998; 153: 251–263.
Hanna MG, Nelson IP. Genetics and molecular pathogenesis of mitochondrial respiratory chain diseases. CMLS 1999; 55: 691–706.
Flier JS, Underhill L. Mitochondrial DNA and disease. N. Engl. J. Med. 1995; 333: 638–644.
Johns JR. Mitochondrial DNA and disease. N. Engl. J. Med. 1995; 333: 638–644.
Leonard JV, Schapira AHV. Mitochondrial respiratory chain disorders I: Mitochondrial DNA defects. Lancet 2000; 355: 389–394.
Leonard JV, Schapira AHV. Mitochondrial respiratory chain disorders II: Mitochondrial DNA defects. Lancet 2000; 355: 389–394.
Schapira AHV. Mitochondrial disorders. Curr. Opin. Neurol. 2000; 13: 526–532.
Chinnery PF, Turnbull DM. Epidemiology and treatment of mitochondrial disorders. Am. J. Med. Genet. 2001; 106: 94–101.
Griggs RC, Karpati G. Muscle pain, fatigue, and mitochondriopathies. N. Engl. J. Med. 1999; 341: 1076–1078.
Howard RS, Russsell S, Losseff N, et al. Management of mitochondrial disease in the critical care unit. QJM 1995; 88: 197–207.
Dandurand R, Matthews PM, Arnold DL, Eidelman DH. Mitochondrial disease-pulmonary function, excercise performance, and blood lactate levels. Chest 1995; 108: 182–189.
Kimura S, Ohtuki N, Nezu A, Tanaka M, Takeshita S. Clinical and radiological improvements in mitochondrial encephalomyelopathy following sodium dichloroacetate therapy. Brain Dev. 1997; 19: 535–540.
Bargiela-Lemos A, Mosquera J, Mate A, Sirvent J. Myopathy with mitochondrial changes presenting as respiratory failure in two brothers. Pediatr. Pulmonol. 1999; 27: 213–217.
Barohn RJ, Clanton T, Sahenk Z, Mendell JR. Recurrent respiratory insufficiency and depressed ventilatory drive complicating mitochondrial myopathies. Neurology 1990; 40: 103–106.
Penniso-Besnier I, Reynier P, Asfar P, et al. Recurrent brain hematomas in MELAS associated with an ND5 gene mitochondrial mutation. Neurology 2000; 55: 317–318.
Molnar MJ, Valikovics A, Molnar S, et al. Cerebral blood flow and glucose metabolism in mitochondrial disorders. Neurology 2000; 55: 544–548.
Cros D, Palliyath S, DiMauro S, Ramirez C, Shamsia M, Wizer B. Respiratory failure revealing mitochondrial myopathy in adults. Chest 1992; 101: 824–828.
Borel CO, Guy J. Ventilatory management in critical neurologic illness. In: KG J (ed). Neurologic Clinics. Philadelphia: Saunders Company, 1995: 627–644.
Cray SH, Robinson BH, Cox PN. Lactic acidemia and bradyarrhythmia in a child sedated with propofol. Crit. Care Med. 1998; 26: 2087–2092.
Guilleminault C, Phillip P, Robinson A. Sleep and neuromuscular disease: bilevel positive airway pressure by nasal mask as a treatment for sleep disordered breathing in patients with neuromuscular disease. J. Neurol. Neurosurg. Psychiatry 1998; 65: 225–232.
Pfeiffer G, Winkler G, Neunzig P, Wolf W, Thayssen G, Kunze K. Long-term management of acute respiratory failure in metabolic myopathy. Intensive Care Med. 1996; 22: 1406–1409.
Desnuelle C, Pellissier J, Serratrice G. Chronic progressive external ophtalmoplegia (CPEO) associated with diaphragmatic paralysis: succesful treatment with coenzyme Q (CoQ). Neurology 1988; 38: 102.
Tanahashi C, Nakayama A, Yoshida M, Ito M, Hashizume Y. MELAS with the mitochondrial DNA 3243 point mutation: a neuropathological study. Acta. Neuropathol. 2000; 99: 31–38.
Yoneda M, Maeda M, Kimura H, Fujii A, Katayama K, Kuriyama M. Vasogenic edema on MELAS: A serial study with diffusion-weighted MR imaging. Neurology 2001; 53: 2182–2184.
Adams HP, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke. Circulation 1996; 94: 1167–1174.
Broderick JP, Adams HP, Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage-A statement for healthcare professionals from a special Wwriting group of the stroke council, American Heart Association. Stroke 1999; 30: 905–915.
Canafoglia L, Franceschetti S, Antozzi C, et al. Epileptic phenotypes associated with mitochondrial disorders. Neurology 2001; 56: 1340–1346.
Lowenstein DH, Alldredge B. Status epilepticus. N. Engl. J. Med. 1998; 338: 970–976.
Prasad A, Worrall BB, Bertram EH, Bleck TP. Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia 2000; 42: 380–386.
Matsumoto J, Ogawa H, Maeyama R, et al. Successful treatment by direct hemoperfusion of coma possibly resulting from mitochondrial dysfunction in acute valproate intoxication. Epilepsia 1997; 38: 950–953.
Absalon MJ, Harding CO, Fain DR, Mack KJ. Leigh syndrome in an infant resulting from mitochondrial DNA depletion. Pediatr. Neurol. 2001; 24: 60–63.
Young GB, DeRubies DA. Metabolic encephalopathies. In: Young GB, Ropper AH, Bolton CF (eds). Coma and Impaired Consciousness. New York: McGraw-Hill, 1998: 307–392.
Lin Y-C, Lee W-T, Wang P-J, Shen Y-Z. Vocal cord paralysis and hypoventilation in a patient with suspected Leigh disease. Pediatr. Neurol. 1999; 20: 223–225.
Araki S, Hayashi M, Yasaka A, Maruki K. Electrophysiologic brainstem dysfunction in a child with Leigh disease. Pediatr. Neurol. 1997; 16: 329–333.
Marino PL. The organic acidosis. In: Marino PL (ed). The ICU Book, 2nd ed. Baltimore: Williams and Wilkins, 1998: 592–607.
Pincus JH, Itokawa Y, Cooper JR. Enzyme inhibiting factor in subacute necrotizing encephalomyelopathy. Neurology 1969; 19: 841–844.
North JB, Jennett S. Abnormal breathing patterns associated with acute brain damage. Arch. Neurol. 1974; 31: 338–342.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chalela, J.A. (2004). Management of the Patient With Mitochondrial Disease in the Neurosciences Critical Care Unit. In: Suarez, J.I. (eds) Critical Care Neurology and Neurosurgery. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-660-7_31
Download citation
DOI: https://doi.org/10.1007/978-1-59259-660-7_31
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-350-3
Online ISBN: 978-1-59259-660-7
eBook Packages: Springer Book Archive